Peter Jeffrey Conn
Director/Miembro de la Junta en Appello Pharmaceuticals, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Brian Laden | M | - |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | 6 años |
Joe C. Cook | M | 82 |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | 6 años |
Vaughn D. Bryson | M | 85 |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | - |
Howie Furst | M | - |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | - |
William Slattery | M | - |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | - |
Robin Readnour | M | 60 |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | - |
Gráfico relacional
Relaciones con varias empresas
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 6 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Peter Jeffrey Conn
- Red Personal